Weighted Average Number of Shares Outstanding, Diluted of Bionik Laboratories Corp. from 30 Sep 2014 to 31 Mar 2023

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Bionik Laboratories Corp. quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 30 Sep 2014 to 31 Mar 2023.
  • Bionik Laboratories Corp. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 31 Mar 2023 was 6,903,664, a 18% increase year-over-year.
  • Bionik Laboratories Corp. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 6,903,664, a 18% increase from 2021.
  • Bionik Laboratories Corp. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 5,844,006, a 14% increase from 2020.
  • Bionik Laboratories Corp. annual Weighted Average Number of Shares Outstanding, Diluted for 2020 was 5,128,421.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

Bionik Laboratories Corp. Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2023 6,903,664 +1,059,658 +18% 01 Jan 2023 31 Mar 2023 10-K 21 Jun 2023 2023 FY
Q4 2022 6,879,554 +976,194 +17% 01 Oct 2022 31 Dec 2022 10-Q 08 Feb 2023 2023 Q3
Q3 2022 6,879,554 +1,024,042 +17% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2022 2023 Q2
Q2 2022 6,879,554 +1,177,739 +21% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2022 2022 Q1
Q1 2022 5,844,006 01 Jan 2022 31 Mar 2022 10-K 21 Jun 2023 2023 FY
Q4 2021 5,903,360 +776,526 +15% 01 Oct 2021 31 Dec 2021 10-Q 08 Feb 2023 2023 Q3
Q3 2021 5,855,512 +728,678 +14% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022 2023 Q2
Q2 2021 5,701,815 01 Apr 2021 30 Jun 2021 10-Q 10 Aug 2022 2022 Q1
Q4 2020 5,126,834 01 Oct 2020 31 Dec 2020 10-Q 09 Feb 2022 2022 Q3
Q3 2020 5,126,834 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021 2022 Q2
Q4 2018 2,611,538 +1,932,907 +285% 01 Oct 2018 31 Dec 2018 10-Q 11 Feb 2019 2019 Q3
Q3 2018 2,459,169 +1,780,538 +262% 01 Jul 2018 30 Sep 2018 10-Q 13 Nov 2018 2019 Q2
Q2 2018 257,509,141 +160,549,857 +166% 01 Apr 2018 30 Jun 2018 10-Q 14 Aug 2018 2019 Q1
Q4 2017 678,631 -95,683,910 -99% 01 Oct 2017 31 Dec 2017 10-Q 11 Feb 2019 2019 Q3
Q3 2017 678,631 -85,245,831 -99% 01 Jul 2017 30 Sep 2017 10-Q 13 Nov 2018 2019 Q2
Q2 2017 96,959,284 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2018 2019 Q1
Q4 2016 96,362,541 +23,950,009 +33% 01 Oct 2016 31 Dec 2016 10-Q 13 Feb 2018 2018 Q3
Q3 2016 85,924,462 +9,654,107 +13% 01 Jul 2016 30 Sep 2016 10-Q 13 Nov 2017 2018 Q2
Q1 2016 72,455,753 01 Jan 2016 31 Mar 2016 10-KT 30 Jun 2016 2016 FY
Q4 2015 72,412,532 01 Oct 2015 31 Dec 2015 10-Q 14 Feb 2017 2017 Q3
Q3 2015 76,270,355 +26,533,259 +53% 01 Jul 2015 30 Sep 2015 10-Q 14 Nov 2016 2017 Q2
Q3 2014 49,737,096 01 Jul 2014 30 Sep 2014 10-Q 17 Mar 2016 2015 Q3

Bionik Laboratories Corp. Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2022 6,903,664 +1,059,658 +18% 01 Apr 2022 31 Mar 2023 10-K 21 Jun 2023 2023 FY
2021 5,844,006 +715,585 +14% 01 Apr 2021 31 Mar 2022 10-K 21 Jun 2023 2023 FY
2020 5,128,421 01 Apr 2020 31 Mar 2021 10-K 09 Jun 2022 2022 FY
2016 91,784,976 +24,574,710 +37% 01 Apr 2016 31 Mar 2017 10-K 29 Jun 2017 2017 FY
2015 67,210,266 +16,983,718 +34% 01 Jan 2015 31 Dec 2015 10-KT 30 Jun 2016 2016 FY
2014 50,226,548 01 Apr 2014 31 Mar 2015 10-KT 30 Jun 2016 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.